Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Non-Small-Cell Lung × dupilumab × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 23 Blood Specimen Collection 19 Drug Therapy 18 Magnetic Resonance Spectroscopy 13 Radiotherapy 12 Early Intervention, Educational 12 Standard of Care 11 Carboplatin 10 Practice Guidelines as Topic 9 Pemetrexed 9 X-Rays 8 Immunotherapy 8 Surgical Procedures, Operative 7 Methods 7 Exercise 7 Therapeutics 6 Surveys and Questionnaires 6 Psychiatric Rehabilitation 6 Paclitaxel 6 Counseling 6 Biopsy 6 Anterior Temporal Lobectomy 6 Liquid Biopsy 5 Fluorodeoxyglucose F18 5 Erlotinib Hydrochloride 5 osimertinib 4 Thoracic Surgery, Video-Assisted 4 Specimen Handling 4 Radiation 4 Mastectomy, Segmental 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06743581 2024-12-20

Dupi-Cemi

Centre hospitalier de l'Université de Montréal (CHUM)

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡